
Mirjam Heldner
@m84gruen
ID: 876002227969830912
17-06-2017 09:03:01
78 Tweet
88 Followers
84 Following

Networking and mutual empowerment are important for female early-career researchers!👩🔬🩺 ➡️ We share our experience from a pilot project with female neurology residents interested in clinical research - including tipps on how to start your own network. onlinelibrary.wiley.com/doi/pdf/10.111…






Launching #WSC23 sheila martins proudly announces the publication of The WSO- Lancet Neurology which predicts a huge rise in stroke incidence and prevalence with the greatest burden being experienced in low resource settings thelancet.com/pdfs/journals/…




European Stroke Organisation (ESO) guidelines on Primary Angiitis of the Central Nervous System (PACNS) European Stroke Org Thanh Nguyen 🇺🇦 NOW ONLINE! journals.sagepub.com/doi/10.1177/23…


Register for the ESO WISE webinar: “Realise your potential to make an impact in stroke research and practice” with Else C. Sandset and Mirjam Heldner. Join the discussion on 14. December 2023: ow.ly/6B5V50Q4pBe #strokeeducation #stroketwitter #stroke #strokeresearch #strokecare



Stroke Research Center Bern pioneer Heini Mattle receiving the Marco Mumenthaler medal at the 2023 🇨🇭🧠 society meeting! Heini pioneered #stroke #thrombectomy and #PFO closure. Congratulations for those fantastic achievements, commitment for patients and fostering new generations! 🙏❤️🫀🏅


🎉 The captain is 🔙! Stroke Research Center Bern rockstar Urs Martin Fischer is back in action at the old stomping ground Insel Gruppe. 🚀 Brace yourselves for the epic comeback! 🌟 #WelcomeHome #BackInTheGame



The completely revised and updated English #Stroke #Guidelines 2024 from Stroke Research Center Bern Insel Gruppe are available as free download! An indispensable treasure of knowledge and guidance for young stroke physicians. neurologie.insel.ch/fileadmin/Neur… Simon Jung Thomas Meinel & team

Dream come true for stroke neurologists! So much interesting data and trials to be presented at #ESOC2024 in Basel. Check out the trial announcements ... ⬇️⬇️⬇️⬇️ eso-stroke.org/wp-content/upl… eso-stroke.org/wp-content/upl… eso-stroke.org/wp-content/upl… eso-stroke.org/wp-content/upl…

Higher rates of #recanalization with no difference in primary outcome in #TEMPO2 trial, comparing #TNK vs BMT in minor strokes with Intracranial occlusion. Time to choose different outcome measures for minor strokes? Are they really not disabling? European Stroke Org World Stroke Org

Nearly 7% of the ACTION-CVT patients had active cancer. Cancer associated CVT carried increased risk of VTE, bleeding, and death. Check out the paper led by Maria Cristina Vedovati and Maurizio Paciaroni David S Liebeskind, MD, MBA Jim Siegler (@jimsieglermd.bsky.social now) Sami Al Kasab Mirjam Heldner Liqi Shu link.springer.com/article/10.100…